To help meet the Challenge Goal of eliminating suffering and death from cancer by 2015, the NCI must capitalize on the extraordinary momentum generated by advances in human genetic research. The sequencing of the human genome and the annotation of common variations, together with new technologies for analyzing single nucleotide polymorphisms (SNPs), have provided the tools for investigators to actively search for inherited variants in genes that can increase or modify cancer risk. The C-GEMS proposal will use the latest genomic technologies to perform dense whole genome scans to identify and validate susceptibility genes in the induction and progression of breast and prostate cancer, and clarify gene-gene and gene-environment interactions. This work will provide new insights into mechanisms of carcinogenesis, and point the way to novel strategies for meeting the 2015 Challenge Goal by accelerating the prevention, early detection, and treatment of cancer.
| Selinski, Silvia; Blaszkewicz, Meinolf; Ickstadt, Katja et al. (2017) Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer. Carcinogenesis 38:1167-1179 |
| Chanock, Stephen (2009) High marks for GWAS. Nat Genet 41:765-6 |
